Chemical Profiling of Antimicrobial Metabolites from Halophilic Actinomycete Nocardiopsis_sp. Al-H10-1 (KF384482) Isolated from Alang, Gulf of Khambhat, India

Abstract

The overuse of antibiotics has resulted in the development of drug resistant, a major problem in disease curing processes i.e. development of drug resistance. The World Health Organization (WHO) released its first list of the most concerning pathogens for human health in 2017 which suggested that there are total 12 bacterial families which have developed multiple drug resistance and for which novel antibiotics are required immediately (WHO 2017). There is a requirement to explore some novel compounds to overcome this issue. Thus our study aimed at exploration of marine actinomycetes as a valuable resource for novel products with antimicrobial properties. The halophilic actinomycete Nocardiopsis_sp. Al-H10-1 (KF384482) was isolated from saline water (20 m away from shore) of Alang coast (Gulf of Khambhat), Bhavnagar, Gujarat, India. The isolate Al-H10-1 was identified as Nocardiopsis sp. through rigorous morphological and cultural characteristics; the species was confirmed through 16s rRNA phylogenetic analysis. The antimicrobial potential of Nocardiopsis sp. Al-H10-1 was assessed against a range of Gram-positive and Gram-negative bacteria as well as three fungi, there it demonstrated antimicrobial activity against four Gram negative bacteria and one Gram positive bacteria. Further active antimicrobial compounds present in ethyl acetate extract was identified using Gas Chromatography-Mass Spectroscopy (GC-MS). GC-MS analysis showed the presence of 17 compounds which included antimicrobial compounds like 2, 4-bis (1, 1-dimethylethyl)-Phenol, Dibutyl phthalate as well as various types of alkanes and their derivatives.

Bioactive compounds of the Actinomycetes isolated from Garmsar Saline River, Iran

“…The escalating resistance of pathogenic bacteria to antibiotics underscores the need to explore new species of actinomycetes for developing novel bioactive scaffolds, natural compounds, and microbial metabolites (Selim et al, 2021). Unexplored ecosystems present a promising reservoir of novel actinomycetes that may be capable of producing new secondary metabolites (Farda et al, 2022;Trivedi and Thumar, 2021).…”